Welcome to the InfoSci Platform
Rational Drug Design Rational Drug Design: One Target, Many Paths to It

Rational Drug Design Rational Drug Design: One Target, Many Paths to It

Khaled H. Barakat, Michael Houghton, D. Lorne Tyrrel, Jack A. Tuszynski
Copyright: © 2017 |Pages: 31
ISBN13: 9781522517627|ISBN10: 1522517626|EISBN13: 9781522517634
DOI: 10.4018/978-1-5225-1762-7.ch044
Cite Chapter Cite Chapter

MLA

Barakat, Khaled H., et al. "Rational Drug Design Rational Drug Design: One Target, Many Paths to It." Pharmaceutical Sciences: Breakthroughs in Research and Practice, edited by Information Resources Management Association, IGI Global, 2017, pp. 1144-1174. https://doi.org/10.4018/978-1-5225-1762-7.ch044

APA

Barakat, K. H., Houghton, M., Tyrrel, D. L., & Tuszynski, J. A. (2017). Rational Drug Design Rational Drug Design: One Target, Many Paths to It. In I. Management Association (Ed.), Pharmaceutical Sciences: Breakthroughs in Research and Practice (pp. 1144-1174). IGI Global. https://doi.org/10.4018/978-1-5225-1762-7.ch044

Chicago

Barakat, Khaled H., et al. "Rational Drug Design Rational Drug Design: One Target, Many Paths to It." In Pharmaceutical Sciences: Breakthroughs in Research and Practice, edited by Information Resources Management Association, 1144-1174. Hershey, PA: IGI Global, 2017. https://doi.org/10.4018/978-1-5225-1762-7.ch044

Export Reference

Mendeley
Favorite

Abstract

For the past three decades rationale drug design (RDD) has been developing as an innovative, rapid and successful way to discover new drug candidates. Many strategies have been followed and several targets with diverse structures and different biological roles have been investigated. Despite the variety of computational tools available, one can broadly divide them into two major classes that can be adopted either separately or in combination. The first class involves structure-based drug design, when the target's 3-dimensional structure is available or it can be computationally generated using homology modeling. On the other hand, when only a set of active molecules is available, and the structure of the target is unknown, ligand-based drug design tools are usually used. This review describes some recent advances in rational drug design, summarizes a number of their practical applications, and discusses both the advantages and shortcomings of the various techniques used.

Request Access

You do not own this content. Please login to recommend this title to your institution's librarian or purchase it from the IGI Global bookstore.